Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas

Francesco Annibale D'Amore; Judit Meszaros Jørgensen; Ida Blok Sillesen; Erik Segel; Hans Herluf Nørregaard Bentzen; M Thorsgaard; Elisa Pulcynski; Bjarne  Pedersen; Dorte  Gillstrom; Michael Roost Clausen; Peter Kamper; Trine Silkjær; Lars Christian Gormsen; Sirpa Leppä; Helle Toldbod

Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas

Francesco Annibale D'Amore, Judit Meszaros Jørgensen, Ida Blok Sillesen, Erik Segel, Hans Herluf Nørregaard Bentzen, M Thorsgaard, Elisa Pulcynski, Bjarne Pedersen, Dorte Gillstrom, Michael Roost Clausen, Peter Kamper, Trine Silkjær, Lars Christian Gormsen, Sirpa Leppä, Helle Toldbod

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Blood
Volume	124
Issue	21
ISSN	0006-4971
Publication status	Published - 2014

Cite this

D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D., Clausen, M. R., Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S., & Toldbod, H. (2014). Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas. Blood, 124(21).

D'Amore, Francesco Annibale ; Jørgensen, Judit Meszaros ; Sillesen, Ida Blok et al. / Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas. In: Blood. 2014 ; Vol. 124, No. 21.

@article{e1902c8e8b7e4e839d3d962a1dbdf0b7,

title = "Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas",

author = "D'Amore, {Francesco Annibale} and J{\o}rgensen, {Judit Meszaros} and Sillesen, {Ida Blok} and Erik Segel and Bentzen, {Hans Herluf N{\o}rregaard} and M Thorsgaard and Elisa Pulcynski and Bjarne Pedersen and Dorte Gillstrom and Clausen, {Michael Roost} and Peter Kamper and Trine Silkj{\ae}r and Gormsen, {Lars Christian} and Sirpa Lepp{\"a} and Helle Toldbod",

year = "2014",

language = "English",

volume = "124",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "21",

}

D'Amore, FA , Jørgensen, JM, Sillesen, IB, Segel, E, Bentzen, HHN, Thorsgaard, M, Pulcynski, E, Pedersen, B, Gillstrom, D, Clausen, MR, Kamper, P , Silkjær, T , Gormsen, LC, Leppä, S & Toldbod, H 2014, 'Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas', Blood, vol. 124, no. 21.

Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas. / D'Amore, Francesco Annibale ; Jørgensen, Judit Meszaros; Sillesen, Ida Blok et al.
In: Blood, Vol. 124, No. 21, 2014.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas

AU - D'Amore, Francesco Annibale

AU - Jørgensen, Judit Meszaros

AU - Sillesen, Ida Blok

AU - Segel, Erik

AU - Bentzen, Hans Herluf Nørregaard

AU - Thorsgaard, M

AU - Pulcynski, Elisa

AU - Pedersen, Bjarne

AU - Gillstrom, Dorte

AU - Clausen, Michael Roost

AU - Kamper, Peter

AU - Silkjær, Trine

AU - Gormsen, Lars Christian

AU - Leppä, Sirpa

AU - Toldbod, Helle

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

SN - 0006-4971

VL - 124

JO - Blood

JF - Blood

IS - 21

ER -